Literature DB >> 3103603

Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III.

E Holm, K Sletten, G Husby.   

Abstract

The amino acid sequence of the variable region of a carbohydrate-containing amyloid-fibril protein MOL of immunoglobulin-light-chain type (AL) was elucidated. The sequence determination involved cleaving the protein with CNBr, BNPS-skatole, thermolysin and trypsin. The sequenced protein consisted of about 130 amino acid residues; however, gel-filtration and N-terminal analysis studies revealed AL proteins ranging in Mr from about 10,000 to 25,000. The oligosaccharide chain was found to be bound in the hypervariable region. By sequence homology to other lambda chains the AL protein MOL was shown to be of the V lambda III subgroup.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3103603      PMCID: PMC1147321          DOI: 10.1042/bj2390545

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda).

Authors:  K G Toft; K Sletten; G Husby
Journal:  Biol Chem Hoppe Seyler       Date:  1985-07

3.  Amyloid fibrils derived from V-region together with C-region fragments from a lambda II-immunoglobulin light chain (HAR).

Authors:  M Eulitz; R Linke
Journal:  Biol Chem Hoppe Seyler       Date:  1985-09

4.  The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.

Authors:  T Tveteraas; K Sletten; P Westermark
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

5.  The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.

Authors:  K Sletten; J B Natvig; G Husby; J Juul
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

Review 6.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

Review 7.  The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins.

Authors:  R D Marshall
Journal:  Biochem Soc Symp       Date:  1974

8.  Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains.

Authors:  H C Sox; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

9.  Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).

Authors:  G Husby; K Sletten; N Blumenkrantz; L Danielsen
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).

Authors:  A Solomon; B Frangione; E C Franklin
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more
  9 in total

1.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 2.  Antibody variable region glycosylation: biochemical and clinical effects.

Authors:  A Wright; S L Morrison
Journal:  Springer Semin Immunopathol       Date:  1993

3.  The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL).

Authors:  E M Fykse; K Sletten; G Husby; G G Cornwell
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

4.  A role for destabilizing amino acid replacements in light-chain amyloidosis.

Authors:  M R Hurle; L R Helms; L Li; W Chan; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

6.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

7.  Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.

Authors:  P Aucouturier; A A Khamlichi; J L Preud'homme; M Bauwens; G Touchard; M Cogné
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

8.  Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability.

Authors:  Fleur S van de Bovenkamp; Ninotska I L Derksen; Mariëlle J van Breemen; Steven W de Taeye; Pleuni Ooijevaar-de Heer; Rogier W Sanders; Theo Rispens
Journal:  Front Immunol       Date:  2018-04-12       Impact factor: 7.561

9.  Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule.

Authors:  Tao Huang; Xueling Chen; Huan Gu; Conghui Zhao; Xingmu Liu; Meiling Yan; Xiaodong Deng; Zaiping Zhang; Jiang Gu
Journal:  Oncotarget       Date:  2016-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.